Author: Hassan Masood

Trading Signals

Kintara Therapeutics, Inc. (KTRA) Stock on a Steep Rise, Here’s Why

 Kintara Therapeutics, Inc. (KTRA), a clinical-stage drug development company, closed Monday’s regular trading session at $0.50 after rocketing by 35.41% during the day. In the aftermarket, KTRA stock has further surged by 3.43% and as a result, is trading at $0.52 at the time of